Neurazon
Company

Last deal

Amount

Seed

Stage

01.06.2022

Date

1

all rounds

General

About Company
Neurazon is the first company to use AI for diagnosing intellectual disabilities.

Industry

Sector :

Subsector :

Also Known As

AiDi

founded date

01.01.2021

Number of employees

Company Type

For Profit

Last funding type

Seed

IPO status

Private

Description

Neurazon's technology uses behavioural and physiological data to provide an accurate assessment of mental ability in children and newborns within minutes. The company is dedicated to developing new technologies and products that aid in the treatment and diagnosis of developmental disorders in this demographic. Their focus is on intelligence augmentation, and they are committed to making a positive impact on the lives of children and families affected by these conditions.
Contacts

Phone number

Social url